Home›Search›Advances in Hematology

Advances in Hematology

John Wiley and Sons Ltd · United Kingdom · Est. 1970

ISSN1687-9104eISSN1687-9112

SJR Q3✓ Scopus / SJR✓ DOAJ✓ Open Access

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.439

H-Indexi

SNIPi

1.072

Total Worksi

409

Total Citationsi

8,483

2yr Mean Citednessi

1.00

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Subject areas: Hematology.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1970

Annual Volume~ 21 articles / year

StatusActive (last: 2026)

Total Publications409

Publisher OrgHindawi Publishing Corporation

OA Since2008

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

OA LicenseCC BY

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/11 · 91%

✅

Do you know the journal / publisher?

John Wiley and Sons Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1687-9104 / 1687-9112

✅

Indexed in a trusted database?

Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

310

2019

295

2020

109

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HematologyQ3

Subject Classification

Scopus Categories

Hematology

Research Topics (OpenAlex)

Hemoglobinopathies and Related DisordersLymphoma Diagnosis and TreatmentIron Metabolism and DisordersChronic Lymphocytic Leukemia ResearchBlood groups and transfusionAcute Myeloid Leukemia ResearchMultiple Myeloma Research and TreatmentsAcute Lymphoblastic Leukemia researchViral-associated cancers and disordersChronic Myeloid Leukemia Treatments

Frequently asked questions about Advances in Hematology

Is Advances in Hematology a predatory journal?

PubScope has no integrity flags on record for Advances in Hematology: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Advances in Hematology?

Advances in Hematology is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.439.

Is Advances in Hematology indexed in Scopus and Web of Science?

Advances in Hematology is indexed in Scopus, DOAJ.

What is the aims and scope of Advances in Hematology?